Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer

Published:2009-11 Issue:8 Volume:19 Page:1329-1334
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Tsiatas Marinos L.,Gyftaki Reveka,Liacos Cristine,Politi Ekaterini,Rodolakis Alexandros,Dimopoulos Meletios-Athanasios,Bamias Aristotelis

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference20 articles.

1. Cancer Statistics, 2007

2. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

3. Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin–paclitaxel chemotherapy

4. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

5. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometriosis-associated ovarian cancer: a different clinical entity;International Journal of Gynecologic Cancer;2024-03-25

2. Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy;Frontiers in Immunology;2022-10-20

3. Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy;Life Sciences;2022-10

4. Identification of CD8+ T Cell Related Biomarkers in Ovarian Cancer;Frontiers in Genetics;2022-05-27

5. Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer;BMC Cancer;2022-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3